NEW YORK, March 27 (Reuters) - Johnson & Johnson ( JNJ )
will get a new chance to contest the scientific evidence linking
talc products to ovarian cancer, a federal judge ruled on
Wednesday, potentially disrupting a federal court case that
consolidates 53,000 lawsuits.